IP Library › Patent Application 19061871
Patent Application
App. No. 19/061,871

SICKLED BETA GLOBIN ANTIBODIES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/061,871
Abstract

The invention provides anti-β S globin antibodies or antigen binding fragments thereof.

Claims (6)

1 .- 10 . (canceled)

11 . A method of detecting β S in a blood sample from a subject, comprising staining the sample with an anti-β S globin antibody or antigen binding fragment thereof comprising a light chain variable region comprising CDR1 (SEQ ID NO: 1), CDR2 (SEQ ID NO: 2), and CDR3 (SEQ ID NO: 3) and a heavy chain variable region comprising CDR1 (SEQ ID NO: 4), CDR2 (SEQ ID NO: 5), and CDR3 (SEQ ID NO: 6).

12 . The method of claim 11 , wherein the anti-β S globin antibody or antigen binding fragment thereof recognizes a β S , E6V mutation.

13 . The method of claim 11 , wherein the anti-β S globin antibody or antigen binding fragment that binds the human β S globin polypeptide is an scFv.

14 . The method of claim 11 , wherein the anti-β S globin antibody or antigen binding fragment thereof coupled with a detectable label.

15 . The method of claim 14 , wherein the detectable label is selected from the group consisting of: a hapten, a fluorescent dye, a fluorescent protein, a chromophore, a metal ion, a gold particle, a silver particle, a magnetic particle, a polypeptide, an enzyme, a luminescent compound, or an oligonucleotide.

Assignments (2)
CHANGE OF NAME Recorded Sep 25, 2025
From: BLUEBIRD BIO, INC.
To: GENETIX BIOTHERAPEUTICS INC.
Reel/Frame 072955/0154 →
SECURITY INTEREST Recorded Mar 28, 2025
From: BLUEBIRD BIO, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 070661/0075 →